| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Plastic isn't just everywhere - it's everything. From the food we buy to the cars we drive, the global plastics economy is worth more than $800 billion. But its future hinges on one critical shift: moving waste from liability to asset. That shift depends on proof - the ability to verify recycled content with the same rigor as virgin plastic. Without it, recycling stalls, ESG pledges collapse into greenwashing, and entire supply chains lose value.
SMX (NASDAQ:SMX) is tackling that credibility gap head-on. In its first major U.S. initiative, the company has stepped into the market with a well-regarded Miami plastics distributor to integrate its molecular marker technology into rPET resin in line with FDA regulations for Food Contact Substances (21 CFR). In practice, this means recycled material can carry a permanent, invisible marker that confirms its origin, composition, and compliance, even in food-grade packaging, one of the industry's strictest categories.
This happens at an opportune time. For decades, recycled plastic has been treated as a second-class material, rarely making it into applications that demand rigorous oversight. By showing that molecular markers can operate within FDA-regulated frameworks, SMX has opened the door for recycled plastics to move beyond discount markets and into premium categories. That's not a symbolic shift. It's a revaluation of plastic waste itself.
Posted In: SMX
